Too Much Information?

USA Today takes a look at the rapid uptake of chromosomal microarrays for prenatal testing, noting that while the approach can detect more genetic abnormalities than current methods like karyotyping, the significance of many of these variants is often unknown.

"Our capacity to test and our capacity to make sense of the results are not well-aligned," Rachel Grob, the author of a book on prenatal and neonatal genetic testing, tells the paper.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.

Intellia Therapeutics has raised $70 million, becoming the latest firm leveraging the gene editing technology to haul in a gob of cash.

Now going beyond reporting fetal aneuploidies, NIPTs may be providing too much information that may be useless, some doctors and genetic counselor say.

A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.